CARLE FOUNDATION HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.5M
- Transactions
- 1,273
- Companies
- 40
- Average per transaction
- $3,518
Who reported the payments
| Medtronic | $539,289 |
| AbbVie | $422,864 |
| Biontech SE | $388,720 |
| AstraZeneca | $283,446 |
| Janssen Research & Development, LLC | $238,073 |
| Boston Scientific | $215,846 |
| Ipsen Bioscience Inc. | $152,674 |
| Regeneron | $142,551 |
| E.r. Squibb & Sons, L.L.C. | $133,861 |
| Takeda Pharmaceuticals U.S.A., Inc. | $126,357 |
| Prenosis Inc. | $118,381 |
| Novartis | $94,013 |
| Bristol Myers Squibb | $88,467 |
| Eisai Inc. | $88,134 |
| Carl Zeiss Meditec, Inc. | $85,639 |
| Fujifilm Healthcare Americas Corporation | $81,647 |
| Genentech, Inc. | $76,236 |
| Premia Spine, Ltd. | $65,951 |
| Cathworks, Inc. | $65,778 |
| Astrazeneca UK Limited | $61,123 |
| Amgen | $58,742 |
| Stryker | $58,238 |
| Immedica Pharma US, Inc. | $51,994 |
| Cerapedics Inc. | $49,878 |
| Pfizer | $46,496 |
| Heartflow, Inc. | $40,800 |
| Seagen Inc. | $39,061 |
| Merck | $38,024 |
| Olympus Corporation Of The Americas | $36,727 |
| Orthofix Medical, Inc. | $35,860 |
| Sage Therapeutics, LLC | $32,250 |
| Advanced Bionics, LLC | $31,478 |
| Spectrum Pharmaceuticals Inc. | $29,997 |
| Daiichi Sankyo Inc. | $27,605 |
| Kowa Research Institute, Inc. | $26,631 |
| Philips North America LLC | $26,198 |
| Eli Lilly | $25,663 |
| Sumitomo Pharma America, Inc. | $24,355 |
| Incyte Corporation | $23,506 |
| KARL Storz Endoscopy-america | $20,360 |